Product Images Potassium Citrate Extended Release

Each extended-release tablet contains 5 mEq (540 m) potassium citrate, USP. The tablets are uncoated, pale yellow, bi-convex, round-shaped, debossed with 'S406' on one side and plain on the other. The usual dosage and full prescribing information can be found in the package insert, which should be dispensed with the bottle by pharmacists. This medication should be kept in a tight container at 20°-25°C (68°-77°F), with excursions permitted between 15°-30°C (59°-86°F) in a controlled room. This product has been manufactured by Strides Pharma Science Ltd in India and distributed by Strides Pharma Inc in East Brunswick, NJ.*

Each tablet contains 10mEq (1080mg) of potassium citrate with NDC number 42543-407-01. The tablet is pale yellow, uncoated, biconvex, caplet shaped with an imprint of 'S407' on one side and plain on the other. It is distributed by Strides Pharma Inc. The usual dosage should be referred to the package insert for full prescribing information. The tablets should be kept in a tight container at a temperature of 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The pharmacist should dispense this drug in the original container without repackaging. The package insert should come with the bottle.*

This is a prescription drug called Potassium Citrate Extended-Release Tablets, USP. Each tablet contains 15 mEq (1620 mg) of the drug, and is pale yellow and bi-convex in shape. The tablet is uncoated and has '5408' imprinted on one side. The recommended dosage can be found in the package insert, and it is important to keep this and all drugs out of the reach of children. It should be stored in a tight container at a temperature between 20-25°C, with excursions permitted between 15-30°C. The package is manufactured by Strides Pharma Science Ltd., Puducherry, India and distributed by Strides Pharma Inc., East Brunswick, NJ 08816.*